Kathryn E. Collingham

714 total citations
10 papers, 545 citations indexed

About

Kathryn E. Collingham is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, Kathryn E. Collingham has authored 10 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Hepatology and 2 papers in Genetics. Recurrent topics in Kathryn E. Collingham's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Kathryn E. Collingham is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Kathryn E. Collingham collaborates with scholars based in United Kingdom and Canada. Kathryn E. Collingham's co-authors include Suparno Chakrabarti, Donald Milligan, Chris Fegan, Vivien Mautner, Paul E. Klapper, Paul Moss, Husam Osman, Susan J. Skidmore, Deenan Pillay and Daina Ratcliffe and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Kathryn E. Collingham

10 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn E. Collingham United Kingdom 7 406 222 165 129 124 10 545
Rudolf Stefan Ross Germany 10 355 0.9× 85 0.4× 83 0.5× 160 1.2× 209 1.7× 14 723
K.E. Collingham United Kingdom 12 302 0.7× 132 0.6× 114 0.7× 164 1.3× 61 0.5× 16 398
G Vergani United Kingdom 8 435 1.1× 51 0.2× 48 0.3× 66 0.5× 95 0.8× 11 672
Marie Hintz United States 9 590 1.5× 48 0.2× 105 0.6× 142 1.1× 36 0.3× 10 687
Stavroula Masouridi‐Levrat Switzerland 14 309 0.8× 41 0.2× 165 1.0× 170 1.3× 170 1.4× 60 603
Piotr Grabarczyk Poland 14 398 1.0× 37 0.2× 86 0.5× 180 1.4× 47 0.4× 66 686
Paula Amat Spain 16 351 0.9× 43 0.2× 126 0.8× 115 0.9× 153 1.2× 46 625
Michèle Aymard France 8 382 0.9× 50 0.2× 57 0.3× 148 1.1× 14 0.1× 10 510
L. H. Barbosa United States 12 873 2.2× 51 0.2× 27 0.2× 201 1.6× 62 0.5× 16 1.1k
Nuria Ortiz‐Movilla Spain 13 428 1.1× 97 0.4× 35 0.2× 112 0.9× 8 0.1× 18 709

Countries citing papers authored by Kathryn E. Collingham

Since Specialization
Citations

This map shows the geographic impact of Kathryn E. Collingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Collingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Collingham more than expected).

Fields of papers citing papers by Kathryn E. Collingham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Collingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Collingham. The network helps show where Kathryn E. Collingham may publish in the future.

Co-authorship network of co-authors of Kathryn E. Collingham

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn E. Collingham. A scholar is included among the top collaborators of Kathryn E. Collingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn E. Collingham. Kathryn E. Collingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chakrabarti, Suparno, Vivien Mautner, Husam Osman, et al.. (2002). Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood. 100(5). 1619–1627. 321 indexed citations
2.
Chakrabarti, Suparno, Kathryn E. Collingham, Timothy Marshall, et al.. (2001). RESPIRATORY VIRUS INFECTIONS IN ADULT T CELL-DEPLETED TRANSPLANT RECIPIENTS: THE ROLE OF CELLULAR IMMUNITY. Transplantation. 72(8). 1460–1463. 29 indexed citations
3.
Chakrabarti, Suparno, et al.. (2000). Resistance to Antiviral Drugs in Herpes Simplex Virus Infections among Allogeneic Stem Cell Transplant Recipients: Risk Factors and Prognostic Significance. The Journal of Infectious Diseases. 181(6). 2055–2058. 95 indexed citations
4.
Skidmore, Susan J. & Kathryn E. Collingham. (1999). Prevalence of GB virus-C/hepatitis G virus infection in an antenatal population. Journal of Medical Virology. 57(3). 235–235. 1 indexed citations
5.
Skidmore, Susan J. & Kathryn E. Collingham. (1999). Prevalence of GB virus-C/hepatitis G virus infection in an antenatal population. Journal of Medical Virology. 57(3). 235–237. 6 indexed citations
6.
Davison, Suzanne, et al.. (1998). Chronic hepatitis in children after liver transplantation: role of hepatitis C virus and hepatitis G virus infections. Journal of Hepatology. 28(5). 764–770. 14 indexed citations
7.
Wilde, Jonathan T., et al.. (1997). Hepatitis G virus infection in patients with bleeding disorders. British Journal of Haematology. 99(2). 285–288. 6 indexed citations
8.
Skidmore, Susan J., et al.. (1997). High Prevalence of Hepatitis G Virus in Bone Marrow Transplant Recipients and Patients Treated for Acute Leukemia. Blood. 89(10). 3853–3856. 24 indexed citations
9.
Skidmore, Susan J., et al.. (1997). High Prevalence of Hepatitis G Virus in Bone Marrow Transplant Recipients and Patients Treated for Acute Leukemia. Blood. 89(10). 3853–3856. 2 indexed citations
10.
Skidmore, Susan J., et al.. (1994). Brief report: Sexual transmission of hepatitis C. Journal of Medical Virology. 42(3). 247–248. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026